Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society

• Autor(a) principal: Bertoluci, Marcello Casaccia
• Data de Publicação: 2014
• Outros Autores: Pimazoni-Netto, Augusto [UNIFESP], Pires, Antonio Carlos, Pesaro, Antonio Eduardo, Schaan, Beatriz D., Caramelli, Bruno, Polanczyk, Carisi Anne, Serrano Junior, Carlos Vicente, Gualandro, Danielle M., Malerbi, Domingos Augusto, Moriguchi, Emilio, Borelli, Flavio Antonio de Oliveira, Salles, Joao Eduardo Nunes, Mariani Junior, Jose, Rohde, Luis Eduardo, Canani, Luis H., Cesar, Luiz Antonio Machado, Tambascia, Marcos, Zanella, Maria Tereza [UNIFESP], Gus, Miguel, Scheffel, Rafael Selbach, Santos, Raul Dias dos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1186/1758-5996-6-58; http://repositorio.unifesp.br/handle/11600/37775
• topic: Diabetes; Glicemic control; Cardiovascular risk stratification; Screening coronary artery disease; Treatment of dyslipidemia; Hypertension; Antiplatelet therapy; Myocardial revascularization

There is a very well known correlation between diabetes and cardiovascular disease but many health care professionals are just concerned with glycemic control, ignoring the paramount importance of controlling other risk factors involved in the pathogenesis of serious cardiovascular diseases. This Position Statement from the Brazilian Diabetes Society was developed to promote increased awareness in relation to six crucial topics dealing with diabetes and cardiovascular disease: Glicemic Control, Cardiovascular Risk Stratification and Screening Coronary Artery Disease, Treatment of Dyslipidemia, Hypertension, Antiplatelet Therapy and Myocardial Revascularization. the issue of what would be the best algorithm for the use of statins in diabetic patients received a special attention and a new Brazilian algorithm was developed by our editorial committee. This document contains 38 recommendations which were classified by their levels of evidence (A, B, C and D). the Editorial Committee included 22 specialists with recognized expertise in diabetes and cardiology.